Antibiotics revolutionised medicine. But bacteria are fighting back — and winning. Now scientists are turning to an ancient, microscopic predator that has been hunting bacteria for three billion years.
When Alexander Fleming discovered penicillin in 1928, it changed the world. Infections that had killed millions — pneumonia, tuberculosis, infected wounds — suddenly became treatable. For decades, antibiotics were our greatest weapon against bacteria.
But there is a problem. Every time we use an antibiotic, any bacteria that survive pass on their resistance to the next generation. Decades of overuse in medicine and farming have bred a new generation of "superbugs" — bacteria that our drugs can no longer kill.
This is not a problem on the horizon — it is happening right now. Drug-resistant infections already kill more people each year than HIV or malaria. And the antibiotic pipeline — the number of new drugs being developed — is dangerously thin. Science needs a completely different approach.
"Bacteria are evolving faster than we can develop new drugs. We need weapons that evolve with them — and nature already built exactly that."
A bacteriophage — "phage" for short — is a virus. But unlike the viruses that make us ill, phages only attack bacteria. They cannot infect human cells. The name comes from the Greek for "bacteria eater," and that is precisely what they do.
Phages are everywhere — in soil, in seawater, in your gut. There are more phages on Earth than every other living thing combined. And for three billion years, long before humans existed, they have been the planet's primary bacterial control system.
If bacteria are the villain, phages are the specialist bounty hunters that evolved specifically to track them down. While antibiotics are like dropping a bomb — killing good and bad bacteria alike — each phage targets one specific species of bacteria and leaves everything else completely untouched.
Scientists have found two clever ways to turn phages into vaccines. First, they can engineer phages to carry surface markers from dangerous bacteria — essentially a "wanted poster" that trains your immune system to recognise the real threat before it arrives. Second, phages can act as both vaccine and medicine simultaneously — killing bacteria while triggering protective immunity at the same time. Your body is armed and ready before infection even begins.
Phage vaccines do not just fight superbugs — they exploit a clever quirk of bacterial evolution to trap them with nowhere to go.
If a phage vaccine prevents infection before it starts, there is no need for antibiotics at all. Less use means slower spread of resistance — breaking the cycle at its root.
When bacteria evolve to resist phages, they often shed the very features that make them dangerous. Phages can literally force bacteria to become weaker to survive.
Like mRNA vaccines for Covid, phage vaccines can be updated quickly when bacteria change. No more waiting a decade for a new antibiotic to be approved and manufactured.
Antibiotics wipe out your gut microbiome along with the infection. Phages target only the harmful bacteria — leaving the billions of beneficial ones completely unharmed.
Imagine a bacterium has two shields: one that makes it drug-resistant, and one that lets it stick to your cells. Phages attack the second shield. To escape, the bacterium has to drop that shield — but in doing so, it becomes far less dangerous and far easier to treat with conventional medicines. The bacteria can dodge the phage, but only by making itself weaker. Scientists call this boxing bacteria into a corner.
Research is most advanced against a group of bacteria known as the ESKAPE pathogens — six organisms responsible for the majority of life-threatening drug-resistant infections in hospitals around the world.
Phage vaccines are genuinely exciting — but good science is always honest about what is still unknown. This is a young and rapidly developing field, and several real challenges remain.
The human body can sometimes produce antibodies against the phages themselves, potentially reducing their effectiveness over time. Because each phage targets one specific bacterium, a single phage may not cover every strain circulating in a population. Regulatory agencies are still developing the legal frameworks needed to approve phage-based medicines at scale. And manufacturing them consistently at the quantities needed for mass vaccination is technically demanding. None of these problems are insurmountable — but they are real, and honest science always acknowledges them.
Clinical trials are underway or in planning for several phage-based treatments, and a growing number of compassionate-use cases — where doctors have used phage therapy on critically ill patients with no other options — have shown remarkable results. The science is moving fast.
For most of the 20th century, antibiotics were our greatest tool against bacterial disease. But that era is ending — not with a bang, but with the quiet, relentless spread of resistance. Phage vaccines represent one of the most coherent scientific responses we have.
They work with nature rather than against it, exploiting three billion years of evolutionary pressure already done for us. They can be adapted rapidly, target bacteria with precision, and force bacteria to become less dangerous in the very act of resisting them — a trick no antibiotic can perform.
We are not yet at the finish line. But for the first time in a long time, science has genuine reason for optimism.